Neurobehavioural effects of developmental toxicity

Author(s): Grandjean P, Landrigan PJ

Abstract

Neurodevelopmental disabilities, including autism, attention-deficit hyperactivity disorder, dyslexia, and other cognitive impairments, affect millions of children worldwide, and some diagnoses seem to be increasing in frequency. Industrial chemicals that injure the developing brain are among the known causes for this rise in prevalence. In 2006, we did a systematic review and identified five industrial chemicals as developmental neurotoxicants: lead, methylmercury, polychlorinated biphenyls, arsenic, and toluene. Since 2006, epidemiological studies have documented six additional developmental neurotoxicants—manganese, fluoride, chlorpyrifos, dichlorodiphenyltrichloroethane, tetrachloroethylene, and the polybrominated diphenyl ethers. We postulate that even more neurotoxicants remain undiscovered. To control the pandemic of developmental neurotoxicity, we propose a global prevention strategy. Untested chemicals should not be presumed to be safe to brain development, and chemicals in existing use and all new chemicals must therefore be tested for developmental neurotoxicity. To coordinate these efforts and to accelerate translation of science into prevention, we propose the urgent formation of a new international clearinghouse.

Similar Articles

Developmental neurotoxicity of industrial chemicals

Author(s): Grandjean P, Landrigan PJ

A tiered approach to systemic toxicity testing for agricultural chemical safety assessment

Author(s): Doe JE, Boobis AR, Blacker A, Dellarco V, Doerrer NG, et al.

Human in vitro reporter model of neuronal development and early differentiation processes

Author(s): Couillard-Despres S, Quehl E, Altendorfer K, Bentley K, Brady AM, et al.

A human pluripotent stem cell platform for assessing developmental neural toxicity screening

Author(s): Hou Z, Zhang J, Schwartz MP, Stewart R, Page CD, et al.

Towards in vitro DT/DNT testing: Assaying chemical susceptibility in early differentiating NT2 cells

Author(s): Menzner AK, AbolpourMofrad S, Friedrich O, Gilbert DF

Neuropharmacological properties of neurons derived from human stem cells

Author(s): Coyne L, Shan M, Przyborski SA, Hirakawa R, Halliwell RF

Optimizing neuronal differentiation of human pluripotent NT2 stem cells in monolayer cultures

Author(s): AbolpourMofrad S, Kuenzel K, Friedrich O, Gilbert DF